Psychosis metabolic risk calculator (PsyMetRiC) in early psychosis: External validation study in Finland.

ABSTRACT:

Introduction

Accurate detection of cardiometabolic risk in early psychosis is crucial to reducing somatic morbidity and mortality in people with psychotic disorders. We conducted an external validation of the psychosis metabolic risk calculator (PsyMetRiC), a cardiometabolic risk prediction tool developed in the UK and tailored for young people with psychosis. We compared the predictive accuracy and clinical usefulness of PsyMetRiC and a general population-based risk prediction tool for type 2 diabetes, the Finnish Diabetes Risk Score (FINDRISC).

Methods

We included first-episode psychosis and ultra-high-risk for psychosis patients without metabolic syndrome aged 18-35 years from the Helsinki Early Psychosis and Turku Early Psychosis Study cohorts. We tested two versions of

SUBMITTER: Keinanen J 

PROVIDER: S-EPMC11608807 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature